课题基金 / 基金详情

To explore the biomarkers which determine the quality of high density lipopotein

To explore the biomarkers which determine the quality of high density lipopotein
探索决定高密度脂蛋白质量的生物标志物
批准号:
23790853
负责人:
YASUDA Tomoyuki
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012

项目摘要

项目成果

YASUDA Tomoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I n the present study, we used rabbit’s and human’s samples for evaluating HDL quality. In basic study, we used the myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHL-MI) rabbits which develop atherosclerotic lesion by month and control Japanese white (JW) rabbits which are healthy control. We evaluated the quantitative or qualitative alteration of HDL in the same individual rabbit. Paraoxonase activity assay, as an antioxidant property of HDL, and cholesterol efflux capacity assay were performed for evaluating HDL quality. There were no differences in HDL quality between 2 rabbit models. HDL qualitative evaluation was performed using the dyslipidemia patients’ serum before and after statin treatment. Statin increased HDL-C levels, and the cholesterol efflux capacity and antioxidant potential of increased HDL were maintained. As mentioned above, both HDL quantities and qualities analysis would be important for evaluating the risk of atherosclerosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pitavastatin increases HDL particles with preserved anti-atherosclerotic properties in dyslipidemic patients
匹伐他汀可增加高密度脂蛋白颗粒,同时保留血脂异常患者的抗动脉粥样硬化特性
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Shibata R, Takahashi R, Kataoka Y, Ohashi K,Ikeda N, Kihara S, Murohara T and Ouchi N, Tomoyuki Yasuda]
通讯作者: Tomoyuki Yasuda
Pitavastatin increases HDL particles functionally-preserved with cholesterol efflux capacity and anti-oxidative action in dyslipidemia patients.
匹伐他汀可增加血脂异常患者中具有胆固醇流出能力和抗氧化作用的高密度脂蛋白颗粒的功能。
DOI: --
发表时间: 2013
期刊: J Atheroscler Thromb
影响因子: 4.4
作者: [Sasaki-Miyamoto M, Yasuda T, Monguchi T, Nakajima H, Mori K, Toh R, Ishida T, Hirata K.]
通讯作者: Hirata K.
Pitavastatin increases HDL particles with preserved anti-atherosclerotic properties in dyslipidemicpatients
匹伐他汀可增加高密度脂蛋白颗粒,并保留血脂异常患者的抗动脉粥样硬化特性
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [中谷和弘, 増田大作, 他, Tomoyuki Yasudaet al]
通讯作者: Tomoyuki Yasudaet al
Analytic investigations of the application of program evaluation methods in psycho-educational/social work practices
  • 批准号:
    21730567
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $1.58万
  • 财政年份:
    2009
  • 负责人:
    YASUDA Tomoyuki
  • 依托单位:
To discover a novel therapy for preventing atherosclerosis by modulating the interaction between endothelial cell s- monocytes
  • 批准号:
    20790530
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.75万
  • 财政年份:
    2008
  • 负责人:
    YASUDA Tomoyuki
  • 依托单位:
国内基金
海外基金
胎源性apoL1甲基化通过调控高密度脂蛋白HDL功能参与脂质代谢的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    周赤燕
  • 依托单位:
LXRα/SR-BI调控脑微血管内皮细胞选择性摄入HDL在慢性脑低灌注所致认知障碍中的作用研究
  • 批准号:
    82301774
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    吴冬梅
  • 依托单位:
复合功能HDL纳米粒用于深静脉血栓形成精准诊疗的基础研究
  • 批准号:
    82370500
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    曾秋
  • 依托单位:
基于肠源性HDL3调控LPS介导Kupffer-肝细胞cross-talk探讨脾虚膏脂转输障碍的分子机制
  • 批准号:
    82374423
  • 项目类别:
    面上项目
  • 资助金额:
    51万元
  • 批准年份:
    2023
  • 负责人:
    杨关林
  • 依托单位: